Naval Shield: Missile Defense at Sea
Discover companies at the forefront of naval missile defense technology. These carefully selected stocks represent the manufacturers behind the ships, combat systems, and interceptors that recently proved their effectiveness in real-world scenarios.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
RTX Corp
RTX
Current price
$153.66
As the manufacturer of the Standard Missile-3 (SM-3) interceptors and the advanced AN/SPY-6 radar, the company is a direct beneficiary of missile cons...
As the manufacturer of the Standard Missile-3 (SM-3) interceptors and the advanced AN/SPY-6 radar, the company is a direct beneficiary of missile consumption and the need for upgraded naval defense systems.
Lockheed Martin Corporation
LMT
Current price
$441.10
Lockheed Martin is the prime contractor for the Aegis Combat System, the central command-and-control brain that enables the destroyers to detect, trac...
Lockheed Martin is the prime contractor for the Aegis Combat System, the central command-and-control brain that enables the destroyers to detect, track, and intercept ballistic missiles.
Huntington Ingalls Industries, Inc.
HII
Current price
$265.40
As one of only two companies that builds the Arleigh Burke-class guided-missile destroyers, Huntington Ingalls is critical to expanding and maintainin...
As one of only two companies that builds the Arleigh Burke-class guided-missile destroyers, Huntington Ingalls is critical to expanding and maintaining the fleet used for these missions.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This collection focuses on defense contractors that are integral to maritime missile defense systems. Following the US Navy's successful interception of Iranian missiles, these companies are positioned to benefit from increased defense spending, fleet expansion, and the urgent need to replenish expended missile inventories.
What You Need to Know
These companies represent the top of the defense value chain, serving as prime contractors and key suppliers with high barriers to entry. They manufacture everything from destroyers themselves to radar systems, interceptor missiles, and command-and-control software that make naval missile defense possible.
Why These Stocks
Each company was selected for its direct involvement in the naval defense supply chain. From shipbuilders to microelectronics providers, these stocks offer concentrated exposure to a specialized segment of the defense industry particularly relevant in today's geopolitical climate.
Group Performance Snapshot
Stocks Rated Buy by Analysts
12 of 14 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.7% return last month.
Why You'll Want to Watch These Stocks
Real-World Validation
The recent US Navy interception of Iranian missiles wasn't just a news headline—it was proof these systems work. This real-combat validation could accelerate contracts and funding.
Budget Boost Coming
With missiles actually being fired in combat, militaries need to replenish their inventories. This urgent restocking, combined with heightened tensions, points to increased defense spending.
High Barriers to Entry
These companies operate in a specialized market with limited competition. Building destroyers and missile systems takes decades of expertise and government relationships that few can match.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.